vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $270.4M, roughly 1.3× Enhabit, Inc.). Walker & Dunlop, Inc. runs the higher net margin — -12.9% vs -14.3%, a 1.4% gap on every dollar of revenue. On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs -0.4%). Enhabit, Inc. produced more free cash flow last quarter ($3.3M vs $-680.1M). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
EHAB vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $340.0M |
| Net Profit | $-38.7M | $-13.9M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | -17.2% |
| Net Margin | -14.3% | -12.9% |
| Revenue YoY | 4.7% | -0.4% |
| Net Profit YoY | 15.9% | -131.0% |
| EPS (diluted) | $-0.76 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $340.0M | ||
| Q3 25 | $263.6M | $337.7M | ||
| Q2 25 | $266.1M | $319.2M | ||
| Q1 25 | $259.9M | $237.4M | ||
| Q4 24 | $258.2M | $341.5M | ||
| Q3 24 | $253.6M | $292.3M | ||
| Q2 24 | $260.6M | $270.7M | ||
| Q1 24 | $262.4M | $228.1M |
| Q4 25 | $-38.7M | $-13.9M | ||
| Q3 25 | $11.1M | $33.5M | ||
| Q2 25 | $5.2M | $34.0M | ||
| Q1 25 | $17.8M | $2.8M | ||
| Q4 24 | $-46.0M | $44.8M | ||
| Q3 24 | $-110.2M | $28.8M | ||
| Q2 24 | $-200.0K | $22.7M | ||
| Q1 24 | $200.0K | $11.9M |
| Q4 25 | -12.3% | -17.2% | ||
| Q3 25 | 6.4% | 13.6% | ||
| Q2 25 | 6.3% | 14.5% | ||
| Q1 25 | 6.1% | 2.2% | ||
| Q4 24 | -16.0% | 15.3% | ||
| Q3 24 | -38.6% | 12.8% | ||
| Q2 24 | 4.3% | 10.4% | ||
| Q1 24 | 4.9% | 6.0% |
| Q4 25 | -14.3% | -12.9% | ||
| Q3 25 | 4.2% | 9.9% | ||
| Q2 25 | 2.0% | 10.6% | ||
| Q1 25 | 6.8% | 1.2% | ||
| Q4 24 | -17.8% | 13.1% | ||
| Q3 24 | -43.5% | 9.9% | ||
| Q2 24 | -0.1% | 8.4% | ||
| Q1 24 | 0.1% | 5.2% |
| Q4 25 | $-0.76 | $-0.41 | ||
| Q3 25 | $0.22 | $0.98 | ||
| Q2 25 | $0.10 | $0.99 | ||
| Q1 25 | $0.35 | $0.08 | ||
| Q4 24 | $-0.92 | $1.32 | ||
| Q3 24 | $-2.20 | $0.85 | ||
| Q2 24 | $0.00 | $0.67 | ||
| Q1 24 | $0.01 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $299.3M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $1.7B |
| Total Assets | $1.2B | $5.1B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $299.3M | ||
| Q3 25 | $56.9M | $274.8M | ||
| Q2 25 | $37.1M | $233.7M | ||
| Q1 25 | $39.5M | $181.0M | ||
| Q4 24 | $28.4M | $279.3M | ||
| Q3 24 | $45.7M | $179.8M | ||
| Q2 24 | $28.5M | $208.1M | ||
| Q1 24 | $36.5M | $216.5M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $1.7B | ||
| Q3 25 | $566.8M | $1.8B | ||
| Q2 25 | $552.4M | $1.8B | ||
| Q1 25 | $543.2M | $1.7B | ||
| Q4 24 | $523.5M | $1.7B | ||
| Q3 24 | $566.1M | $1.7B | ||
| Q2 24 | $674.3M | $1.7B | ||
| Q1 24 | $672.3M | $1.7B |
| Q4 25 | $1.2B | $5.1B | ||
| Q3 25 | $1.2B | $5.8B | ||
| Q2 25 | $1.2B | $4.7B | ||
| Q1 25 | $1.2B | $4.5B | ||
| Q4 24 | $1.2B | $4.4B | ||
| Q3 24 | $1.3B | $4.6B | ||
| Q2 24 | $1.4B | $4.2B | ||
| Q1 24 | $1.4B | $3.8B |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-664.3M |
| Free Cash FlowOCF − Capex | $3.3M | $-680.1M |
| FCF MarginFCF / Revenue | 1.2% | -200.0% |
| Capex IntensityCapex / Revenue | 0.4% | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $-664.3M | ||
| Q3 25 | $37.8M | $-948.1M | ||
| Q2 25 | $10.6M | $-238.5M | ||
| Q1 25 | $17.9M | $-281.1M | ||
| Q4 24 | $-4.1M | $129.4M | ||
| Q3 24 | $28.4M | $-202.0M | ||
| Q2 24 | $9.6M | $-237.8M | ||
| Q1 24 | $17.3M | $38.4M |
| Q4 25 | $3.3M | $-680.1M | ||
| Q3 25 | $36.2M | $-950.4M | ||
| Q2 25 | $8.7M | $-241.0M | ||
| Q1 25 | $17.6M | $-284.7M | ||
| Q4 24 | $-4.7M | $116.4M | ||
| Q3 24 | $27.7M | $-204.0M | ||
| Q2 24 | $8.9M | $-241.7M | ||
| Q1 24 | $15.5M | $35.2M |
| Q4 25 | 1.2% | -200.0% | ||
| Q3 25 | 13.7% | -281.5% | ||
| Q2 25 | 3.3% | -75.5% | ||
| Q1 25 | 6.8% | -120.0% | ||
| Q4 24 | -1.8% | 34.1% | ||
| Q3 24 | 10.9% | -69.8% | ||
| Q2 24 | 3.4% | -89.3% | ||
| Q1 24 | 5.9% | 15.4% |
| Q4 25 | 0.4% | 4.6% | ||
| Q3 25 | 0.6% | 0.7% | ||
| Q2 25 | 0.7% | 0.8% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.2% | 3.8% | ||
| Q3 24 | 0.3% | 0.7% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 0.7% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | -28.34× | ||
| Q2 25 | 2.04× | -7.02× | ||
| Q1 25 | 1.01× | -102.07× | ||
| Q4 24 | — | 2.89× | ||
| Q3 24 | — | -7.01× | ||
| Q2 24 | — | -10.49× | ||
| Q1 24 | 86.50× | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
WD
Segment breakdown not available.
